Phillip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 30,000 shares at $150.00 ($4.5M) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $4.5M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2022-08-17 | $12.8M | — | Filing → |
| ALNY | SELL | 2020-11-30 | $7.5M | — | Filing → |
| ALNY | SELL | 2020-02-13 | $3.9M | — | Filing → |